Breaking News Instant updates and real-time market news.

14:25
09/23/20
09/23
14:25
09/23/20
14:25

Senate Budget Committee to hold a virtual hearing

The Committee holds a virtual hearing to consider the Congressional Budget Office's (CBO) updated budget outlook on September 23 at 2:30 pm. Webcast Link

TODAY'S FREE FLY STORIES

Hot Stocks
Crispr Therapeutics expects to report data from Phase 1 trial of CTX120 in 2021 » 08:10
10/28/20
10/28
08:10
10/28/20
08:10
CRSP

Crispr Therapeutics

$98.05 /

+3.94 (+4.19%)

CRISPR Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

10/22/20 RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/22/20 Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
10/22/20 Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
10/22/20 Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

Hot Stocks
Whirlpool Chief Legal Officer Kirsten Hewitt to retire, Ava Harter to succeed » 08:10
10/28/20
10/28
08:10
10/28/20
08:10
WHR

Whirlpool

$195.89 /

+1.885 (+0.97%)

, OC

Owens Corning

$68.92 /

-0.3 (-0.43%)

Whirlpool (WHR) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

OC Owens Corning
$68.92 /

-0.3 (-0.43%)

WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

10/23/20 JPMorgan
Whirlpool price target raised to $237 from $192 at JPMorgan
10/23/20 Deutsche Bank
Whirlpool price target raised to $199 from $153 at Deutsche Bank
10/23/20 RBC Capital
Whirlpool upgraded to Sector Perform from Underperform at RBC Capital
10/23/20 RBC Capital
Whirlpool upgraded to Sector Perform from Underperform at RBC Capital
OC Owens Corning
$68.92 /

-0.3 (-0.43%)

10/13/20 Benchmark
Benchmark upgrades Owens Corning to Buy, sees 'best set-up in several years'
10/13/20 Benchmark
Owens Corning upgraded to Buy from Hold at Benchmark
09/21/20 Jefferies
Owens Corning named Franchise Pick at Jefferies
09/04/20 Loop Capital
Owens Corning price target raised to $80 from $71 at Loop Capital
WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

OC Owens Corning
$68.92 /

-0.3 (-0.43%)

WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

OC Owens Corning
$68.92 /

-0.3 (-0.43%)

WHR Whirlpool
$195.89 /

+1.885 (+0.97%)

Earnings
Hess Midstream Partners reports Q3 EPS 31c, consensus 35c » 08:10
10/28/20
10/28
08:10
10/28/20
08:10
HESM

Hess Midstream Partners

$17.76 /

+0.495 (+2.87%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HESM Hess Midstream Partners
$17.76 /

+0.495 (+2.87%)

HESM Hess Midstream Partners
$17.76 /

+0.495 (+2.87%)

10/16/20 Citi
Hess Midstream Partners upgraded to Buy from Neutral at Citi
10/15/20 Citi
Hess Midstream Partners upgraded to Buy from Neutral at Citi
10/05/20
Fly Intel: Top five analyst initiations
10/05/20 UBS
Hess Midstream Partners initiated with a Buy at UBS
HESM Hess Midstream Partners
$17.76 /

+0.495 (+2.87%)

Hot Stocks
Crispr Therapeutics to report additional data from Phase 1 CARBON trial in 2021 » 08:10
10/28/20
10/28
08:10
10/28/20
08:10
CRSP

Crispr Therapeutics

$98.05 /

+3.94 (+4.19%)

On October 21, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

10/22/20 RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/22/20 Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
10/22/20 Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
10/22/20 Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

Recommendations
Stanley Black & Decker price target raised to $179 from $163 at Credit Suisse » 08:10
10/28/20
10/28
08:10
10/28/20
08:10
SWK

Stanley Black & Decker

$166.44 /

-6.46 (-3.74%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWK Stanley Black & Decker
$166.44 /

-6.46 (-3.74%)

SWK Stanley Black & Decker
$166.44 /

-6.46 (-3.74%)

06:54 Today Deutsche Bank
Stanley Black & Decker price target raised to $200 from $192 at Deutsche Bank
09/23/20 Citi
Citi ups Stanley Black & Decker target, opens 'Positive Catalyst Watch'
09/14/20 UBS
Stanley Black & Decker price target raised to $184 from $173 at UBS
08/31/20 Baird
Stanley Black & Decker price target raised to $184 from $175 at Baird
SWK Stanley Black & Decker
$166.44 /

-6.46 (-3.74%)

SWK Stanley Black & Decker
$166.44 /

-6.46 (-3.74%)

Hot Stocks
Crispr expects to report data from patients treated with CTX001 in Q4 » 08:09
10/28/20
10/28
08:09
10/28/20
08:09
CRSP

Crispr Therapeutics

$98.05 /

+3.94 (+4.19%)

, VRTX

Vertex Pharmaceuticals

$212.23 /

+5.04 (+2.43%)

CRISPR Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

10/22/20 RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/22/20 Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
10/22/20 Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
10/22/20 Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

06:13 Today UBS
Vertex Pharmaceuticals initiated with a Buy at UBS
10/26/20 Stifel
SAP news impact may be company-specific for software sector, says Stifel
10/15/20 Truist
Vertex Pharmaceuticals price target lowered to $305 from $330 at Truist
10/15/20 Morgan Stanley
VX-814 discontinuation can drive Vertex shares 5%-10% lower, says Morgan Stanley
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

  • 01
    Jul
  • 21
    Nov
VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

VRTX Vertex Pharmaceuticals
$212.23 /

+5.04 (+2.43%)

Upgrade
Red Rock Resorts upgraded to Buy from Hold at Union Gaming » 08:09
10/28/20
10/28
08:09
10/28/20
08:09
RRR

Red Rock Resorts

/

+

Union Gaming analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RRR Red Rock Resorts
/

+

RRR Red Rock Resorts
/

+

07:09 Today Goldman Sachs
Red Rock Resorts price target raised to $26 from $20 at Goldman Sachs
06:51 Today Deutsche Bank
Red Rock Resorts price target raised to $24 from $22 at Deutsche Bank
10/14/20 JPMorgan
Red Rock Resorts price target raised to $23 from $21 at JPMorgan
09/14/20 Goldman Sachs
Red Rock Resorts price target raised to $20 from $15 at Goldman Sachs
RRR Red Rock Resorts
/

+

RRR Red Rock Resorts
/

+

RRR Red Rock Resorts
/

+

Initiation
Repare Therapeutics initiated with an Outperform at Northland » 08:09
10/28/20
10/28
08:09
10/28/20
08:09
RPTX

Repare Therapeutics

$26.32 /

-0.435 (-1.63%)

Northland analyst Tim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPTX Repare Therapeutics
$26.32 /

-0.435 (-1.63%)

RPTX Repare Therapeutics
$26.32 /

-0.435 (-1.63%)

09/25/20 Piper Sandler
Repare Therapeutics viewed as core long-term holding at Piper Sandler
07/14/20
Fly Intel: Top five analyst initiations
07/14/20 Morgan Stanley
Repare Therapeutics initiated with an Overweight at Morgan Stanley
07/14/20 Goldman Sachs
Repare Therapeutics initiated with a Neutral at Goldman Sachs
RPTX Repare Therapeutics
$26.32 /

-0.435 (-1.63%)

  • 19
    Jun
RPTX Repare Therapeutics
$26.32 /

-0.435 (-1.63%)

Hot Stocks
Titan Pharmaceuticals to acquire JT Pharma's JT/09 for chronic pruritus » 08:08
10/28/20
10/28
08:08
10/28/20
08:08
TTNP

Titan Pharmaceuticals

$0.13 /

-0.0209 (-14.04%)

Titan Pharmaceuticals has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TTNP Titan Pharmaceuticals
$0.13 /

-0.0209 (-14.04%)

TTNP Titan Pharmaceuticals
$0.13 /

-0.0209 (-14.04%)

08/17/20 Maxim
Titan Pharmaceuticals downgraded to Hold from Buy at Maxim
08/14/20 Maxim
Titan Pharmaceuticals downgraded to Hold from Buy at Maxim
TTNP Titan Pharmaceuticals
$0.13 /

-0.0209 (-14.04%)

Recommendations
Crocs price target raised to $60 from $45 at Monness Crespi » 08:08
10/28/20
10/28
08:08
10/28/20
08:08
CROX

Crocs

$54.80 /

+2.69 (+5.16%)

Monness Crespi analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CROX Crocs
$54.80 /

+2.69 (+5.16%)

CROX Crocs
$54.80 /

+2.69 (+5.16%)

08:01 Today Susquehanna
Crocs price target raised to $68 from $53 at Susquehanna
07:52 Today Baird
Crocs price target raised to $72 from $50 at Baird
07:21 Today Stifel
Crocs price target raised to $50 from $42 at Stifel
06:43 Today UBS
Crocs price target raised to $57 from $48 at UBS
CROX Crocs
$54.80 /

+2.69 (+5.16%)

  • 31
    Oct
CROX Crocs
$54.80 /

+2.69 (+5.16%)

CROX Crocs
$54.80 /

+2.69 (+5.16%)

CROX Crocs
$54.80 /

+2.69 (+5.16%)

Hot Stocks
TC Energy awards over $1.6B in contracts to build Keystone XL » 08:08
10/28/20
10/28
08:08
10/28/20
08:08
TRP

TC Energy

$41.65 /

+0.23 (+0.56%)

TC Energy has awarded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRP TC Energy
$41.65 /

+0.23 (+0.56%)

TRP TC Energy
$41.65 /

+0.23 (+0.56%)

10/14/20 Goldman Sachs
TC Energy upgraded to Buy from Neutral at Goldman Sachs
08/06/20 BMO Capital
TC Energy price target raised to C$68 from C$65 at BMO Capital
07/15/20 Scotiabank
TC Energy upgraded to Outperform on recent selloff at Scotiabank
07/15/20 Scotiabank
TC Energy upgraded to Outperform from Sector Perform at Scotiabank
TRP TC Energy
$41.65 /

+0.23 (+0.56%)

Recommendations
Ecolab price target raised to $180 from $172 at Credit Suisse » 08:08
10/28/20
10/28
08:08
10/28/20
08:08
ECL

Ecolab

$189.85 /

-8.77 (-4.42%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECL Ecolab
$189.85 /

-8.77 (-4.42%)

ECL Ecolab
$189.85 /

-8.77 (-4.42%)

07:36 Today BMO Capital
Ecolab price target raised to $195 from $187 at BMO Capital
06:53 Today Deutsche Bank
Ecolab price target lowered to $200 from $210 at Deutsche Bank
09/21/20 Evercore ISI
Ecolab initiated with an Outperform at Evercore ISI
09/08/20 BMO Capital
Ecolab price target raised to $187 from $177 at BMO Capital
ECL Ecolab
$189.85 /

-8.77 (-4.42%)

ECL Ecolab
$189.85 /

-8.77 (-4.42%)

ECL Ecolab
$189.85 /

-8.77 (-4.42%)

Earnings
Dine Brands reports Q3 EPS 80c, consensus 36c » 08:07
10/28/20
10/28
08:07
10/28/20
08:07
DIN

Dine Brands

$56.64 /

+0.69 (+1.23%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIN Dine Brands
$56.64 /

+0.69 (+1.23%)

DIN Dine Brands
$56.64 /

+0.69 (+1.23%)

10/14/20 Wedbush
Dine Brands price target raised to $70 from $55 at Wedbush
10/14/20 Wedbush
Dine Brands price target raised to $70 from $55 at Wedbush
07/30/20 Wedbush
Dine Brands price target raised to $55 from $50 at Wedbush
07/30/20 Deutsche Bank
Dine Brands price target raised to $45 from $40 at Deutsche Bank
DIN Dine Brands
$56.64 /

+0.69 (+1.23%)

DIN Dine Brands
$56.64 /

+0.69 (+1.23%)

Hot Stocks
Keurig Dr Pepper signs distribution pact with The Honickman Companies » 08:07
10/28/20
10/28
08:07
10/28/20
08:07
KDP

Keurig Dr Pepper

$28.60 /

+0.17 (+0.60%)

Keurig Dr Pepper and The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KDP Keurig Dr Pepper
$28.60 /

+0.17 (+0.60%)

KDP Keurig Dr Pepper
$28.60 /

+0.17 (+0.60%)

10/20/20 Jefferies
National Beverage upgraded to Hold on better La Croix market share at Jefferies
08/27/20 Jefferies
Keurig Dr Pepper has long runway for pod category growth, says Jefferies
08/26/20
Fly Intel: Top five analyst upgrades
08/26/20 Morgan Stanley
Keurig Dr Pepper upgraded to Overweight on coffee 'boost' at Morgan Stanley
KDP Keurig Dr Pepper
$28.60 /

+0.17 (+0.60%)

  • 18
    Aug
  • 03
    Aug
  • 21
    May
  • 05
    Mar
KDP Keurig Dr Pepper
$28.60 /

+0.17 (+0.60%)

Hot Stocks
General Electric: 'Our markets are, by and large, stabilizing' » 08:06
10/28/20
10/28
08:06
10/28/20
08:06
GE

General Electric

$7.10 /

-0.29 (-3.92%)

Comments taken from Q3…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GE General Electric
$7.10 /

-0.29 (-3.92%)

GE General Electric
$7.10 /

-0.29 (-3.92%)

10/13/20 Deutsche Bank
General Electric price target raised to $6.81 from $6.25 at Deutsche Bank
10/09/20 Goldman Sachs
Goldman sees 50% upside in General Electric, reinstates shares at Buy
09/17/20 JPMorgan
Those calling GE guidance 'inflection' misunderstand business, says JPMorgan
08/31/20 JPMorgan
JPMorgan's Tusa withdraws GE price target, sees fair value below $5
GE General Electric
$7.10 /

-0.29 (-3.92%)

GE General Electric
$7.10 /

-0.29 (-3.92%)

GE General Electric
$7.10 /

-0.29 (-3.92%)

GE General Electric
$7.10 /

-0.29 (-3.92%)

Earnings
First Merchants reports Q3 EPS 67c, consensus 62c » 08:06
10/28/20
10/28
08:06
10/28/20
08:06
FRME

First Merchants

$26.52 /

-0.58 (-2.14%)

Reports tangible common…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRME First Merchants
$26.52 /

-0.58 (-2.14%)

FRME First Merchants
$26.52 /

-0.58 (-2.14%)

06/17/20 Raymond James
First Merchants downgraded to Market Perform from Outperform at Raymond James
04/09/20 Stephens
First Merchants downgraded to Equal Weight on near-term risks at Stephens
04/09/20 Stephens
First Merchants downgraded to Equal Weight from Overweight at Stephens
FRME First Merchants
$26.52 /

-0.58 (-2.14%)

Hot Stocks
MasterCard seeing 'encouraging' progress in domestic spending trajectory » 08:05
10/28/20
10/28
08:05
10/28/20
08:05
MA

MasterCard

$317.12 /

-0.985 (-0.31%)

"Mastercard has been…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

10/05/20 Morgan Stanley
Repay Holdings initiated with an Equal Weight at Morgan Stanley
10/02/20 Jefferies
MasterCard price target raised to $330 from $305 at Jefferies
09/21/20 Barclays
MasterCard price target raised to $385 from $360 at Barclays
09/15/20 Deutsche Bank
MasterCard price target raised to $383 from $320 at Deutsche Bank
MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

Hot Stocks
AbbVie's presbyopia candidate meets efficacy endpoint in Phase 3 trial » 08:05
10/28/20
10/28
08:05
10/28/20
08:05
ABBV

AbbVie

$82.69 /

-1.2 (-1.43%)

AbbVie company Allergan …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$82.69 /

-1.2 (-1.43%)

ABBV AbbVie
$82.69 /

-1.2 (-1.43%)

10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
AbbVie initiated with a Buy at Truist
10/20/20 Goldman Sachs
Galapagos downgraded to Sell from Neutral at Goldman Sachs
ABBV AbbVie
$82.69 /

-1.2 (-1.43%)

ABBV AbbVie
$82.69 /

-1.2 (-1.43%)

ABBV AbbVie
$82.69 /

-1.2 (-1.43%)

Earnings
MasterCard reports Q3 adjusted EPS $1.60, consensus $1.66 » 08:05
10/28/20
10/28
08:05
10/28/20
08:05
MA

MasterCard

$317.12 /

-0.985 (-0.31%)

Reports Q3 revenue $3.8B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

10/05/20 Morgan Stanley
Repay Holdings initiated with an Equal Weight at Morgan Stanley
10/02/20 Jefferies
MasterCard price target raised to $330 from $305 at Jefferies
09/21/20 Barclays
MasterCard price target raised to $385 from $360 at Barclays
09/15/20 Deutsche Bank
MasterCard price target raised to $383 from $320 at Deutsche Bank
MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

Hot Stocks
Norfolk Southern reports Q3 adjusted operating ratio 62.5% » 08:05
10/28/20
10/28
08:05
10/28/20
08:05
NSC

Norfolk Southern

$203.55 /

-7.05 (-3.35%)

The adjusted operating…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

10/16/20 Barclays
Norfolk Southern upgraded to Equal Weight with $230 target at Barclays
10/16/20 Barclays
Norfolk Southern upgraded to Equal Weight from Underweight at Barclays
10/08/20 Susquehanna
Norfolk Southern price target raised to $286 from $284 at Susquehanna
10/08/20 Citi
Norfolk Southern price target raised to $250 from $214 at Citi
NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

Recommendations
Raytheon Technologies price target lowered to $70 from $75 at Credit Suisse » 08:03
10/28/20
10/28
08:03
10/28/20
08:03
RTX

Raytheon Technologies

$56.45 /

-4.44 (-7.29%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

10/12/20 Credit Suisse
Raytheon Technologies price target lowered to $75 from $81 at Credit Suisse
09/20/20 Goldman Sachs
Lockheed Martin downgraded to Buy from Conviction Buy at Goldman Sachs
09/20/20 Goldman Sachs
Raytheon upgraded to Conviction Buy from Buy at Goldman Sachs
09/08/20 Morgan Stanley
Raytheon Technologies initiated with an Overweight at Morgan Stanley
RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

Earnings
Crispr Therapeutics reports Q3 EPS ($1.32), consensus ($1.18) » 08:03
10/28/20
10/28
08:03
10/28/20
08:03
CRSP

Crispr Therapeutics

$98.05 /

+3.94 (+4.19%)

Reports Q3 revenue $0.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

10/22/20 RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/22/20 Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
10/22/20 Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
10/22/20 Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

Earnings
Popular reports Q3 EPS $2.00, consensus $1.20 » 08:03
10/28/20
10/28
08:03
10/28/20
08:03
BPOP

Popular

$39.26 /

-1.31 (-3.23%)

Net interest income for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPOP Popular
$39.26 /

-1.31 (-3.23%)

BPOP Popular
$39.26 /

-1.31 (-3.23%)

09/22/20
Top five analyst initiations
09/22/20 UBS
Popular initiated with a Neutral at UBS
07/07/20 RBC Capital
Popular price target lowered to $48 from $58 at RBC Capital
03/27/20 BTIG
Popular price target lowered to $54 from $60 at BTIG
BPOP Popular
$39.26 /

-1.31 (-3.23%)

Earnings
Dynex Capital reports Q3 core EPS 61c, consensus 47c » 08:03
10/28/20
10/28
08:03
10/28/20
08:03
DX

Dynex Capital

$16.00 /

+0.21 (+1.33%)

Reports Q3 book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DX Dynex Capital
$16.00 /

+0.21 (+1.33%)

07/29/20 Ladenburg
Dynex Capital upgraded to Buy from Neutral at Ladenburg
01/14/20 JonesTrading
Dynex Capital initiated with a Buy at JonesTrading
11/26/19
Fly Intel: Top five analyst upgrades
11/25/19 Keefe Bruyette
Dynex Capital upgraded to Outperform from Market Perform at Keefe Bruyette
DX Dynex Capital
$16.00 /

+0.21 (+1.33%)

DX Dynex Capital
$16.00 /

+0.21 (+1.33%)

Hot Stocks
ADP jumps nearly 5% to $153 after Q1 earnings beat, raised FY21 guidance  08:03
10/28/20
10/28
08:03
10/28/20
08:03
ADP

ADP

$145.95 /

+0.24 (+0.16%)

 
ShowHide Related Items >><<
ADP ADP
$145.95 /

+0.24 (+0.16%)

ADP ADP
$145.95 /

+0.24 (+0.16%)

10/27/20 Credit Suisse
TriNet price target raised to $66 from $54 at Credit Suisse
09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Cowen
ADP downgraded to Market Perform on lack of catalysts at Cowen
09/21/20 Cowen
ADP downgraded to Market Perform from Outperform at Cowen
ADP ADP
$145.95 /

+0.24 (+0.16%)

ADP ADP
$145.95 /

+0.24 (+0.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.